Fig. 3From: Design, synthesis, and biological investigations of new pyrazole derivatives as VEGFR2/CDK-2 inhibitors targeting liver cancerAnti-cancer agents with reactive species: piperidine, morpholine, aniline, and antipyrine [27, 31, 32]Back to article page
